118 related articles for article (PubMed ID: 32100324)
1. Off-label use of quetiapine in nursing homes: Does medical specialty of prescribing physicians play a role?
Müller L; Noseda R; Bertoli R; Bissig M; Ceschi A
Br J Clin Pharmacol; 2020 Jul; 86(7):1444-1445. PubMed ID: 32100324
[No Abstract] [Full Text] [Related]
2. Off label or on trend: a review of the use of quetiapine in New Zealand.
Huthwaite M; Tucker M; McBain L; Romans S
N Z Med J; 2018 May; 131(1474):45-50. PubMed ID: 29723178
[No Abstract] [Full Text] [Related]
3. Challenges to the validity of using medicine labels to categorize clinical behavior: An empirical and normative critique of "off-label" prescribing.
Ghinea N; Kerridge I; Little M; Lipworth W
J Eval Clin Pract; 2017 Jun; 23(3):574-581. PubMed ID: 27859988
[TBL] [Abstract][Full Text] [Related]
4. The challenge of off-label prescribing.
Phillips J
Int J Palliat Nurs; 2015 Sep; 21(9):419. PubMed ID: 26412270
[No Abstract] [Full Text] [Related]
5. Off-label prescribing: in search of a reasonable patient-centered approach.
Rich BA
J Pain Palliat Care Pharmacother; 2012 Jun; 26(2):131-3. PubMed ID: 22764850
[TBL] [Abstract][Full Text] [Related]
6. [The Medical Products Agency is positive to a dialogue about off-label prescribing].
Babra A; Arlander E
Lakartidningen; 2015 May; 112():. PubMed ID: 25988651
[No Abstract] [Full Text] [Related]
7. Off-label indications for antidepressants in primary care: descriptive study of prescriptions from an indication based electronic prescribing system.
Wong J; Motulsky A; Abrahamowicz M; Eguale T; Buckeridge DL; Tamblyn R
BMJ; 2017 Feb; 356():j603. PubMed ID: 28228380
[No Abstract] [Full Text] [Related]
8. The impact of permissive and restrictive pharmaceutical policies on quetiapine dispensing: Evaluating a policy pendulum using interrupted time series analysis.
Brett J; Schaffer A; Dobbins T; Buckley NA; Pearson SA
Pharmacoepidemiol Drug Saf; 2018 Apr; 27(4):439-446. PubMed ID: 29493050
[TBL] [Abstract][Full Text] [Related]
9. Effect of Peer Comparison Letters for High-Volume Primary Care Prescribers of Quetiapine in Older and Disabled Adults: A Randomized Clinical Trial.
Sacarny A; Barnett ML; Le J; Tetkoski F; Yokum D; Agrawal S
JAMA Psychiatry; 2018 Oct; 75(10):1003-1011. PubMed ID: 30073273
[TBL] [Abstract][Full Text] [Related]
10. In Defense of Off-label Prescribing.
Keller DL
JAMA Intern Med; 2016 Jun; 176(6):861. PubMed ID: 27273485
[No Abstract] [Full Text] [Related]
11. In Defense of Off-label Prescribing-Reply.
Eguale T; Verma A; Tamblyn R
JAMA Intern Med; 2016 Jun; 176(6):861-2. PubMed ID: 27273486
[No Abstract] [Full Text] [Related]
12. Characteristics and quality of prescribing by doctors practicing in nursing homes.
Beers MH; Fingold SF; Ouslander JG; Reuben DB; Morgenstern H; Beck JC
J Am Geriatr Soc; 1993 Aug; 41(8):802-7. PubMed ID: 8340556
[TBL] [Abstract][Full Text] [Related]
13. Knowledge and perception of off-label drug use amongst prescribing physicians in a tertiary care hospital.
Kannan S; Bahl A; Khosla PP
Int J Risk Saf Med; 2015; 27(4):219-23. PubMed ID: 26756895
[TBL] [Abstract][Full Text] [Related]
14. Best practices: an intervention to promote evidence-based prescribing at a large psychiatric hospital.
Stowell KR; Ghinassi FA; Fabian TJ; Nash KC; Haskett RF
Psychiatr Serv; 2009 Mar; 60(3):294-6. PubMed ID: 19252040
[TBL] [Abstract][Full Text] [Related]
15. Association of Quetiapine Overuse Letters With Prescribing by Physician Peers of Targeted Recipients: A Secondary Analysis of a Randomized Clinical Trial.
Sacarny A; Olenski AR; Barnett ML
JAMA Psychiatry; 2019 Oct; 76(10):1094-1095. PubMed ID: 31162529
[TBL] [Abstract][Full Text] [Related]
16. The Law and Practice of Off-Label Prescribing and Physician Promotion.
Syed SA; Dixson BA; Constantino E; Regan J
J Am Acad Psychiatry Law; 2021 Mar; 49(1):53-59. PubMed ID: 33234538
[TBL] [Abstract][Full Text] [Related]
17. Off-label prescribing.
Seale JP
Med J Aust; 2014 Feb; 200(2):65. PubMed ID: 24484085
[No Abstract] [Full Text] [Related]
18. Utilisation of extended release quetiapine (Seroquel XL™): Results from an observational cohort study in England.
Osborne V; Davies M; Layton D; Shakir SAW
Eur Psychiatry; 2016 Mar; 33():61-67. PubMed ID: 26872067
[TBL] [Abstract][Full Text] [Related]
19. Off-label prescribing of antidepressants.
Morales DR; Guthrie B
BMJ; 2017 Feb; 356():j849. PubMed ID: 28223288
[No Abstract] [Full Text] [Related]
20. Randomized Study of Providing Evidence Context to Mitigate Physician Misinterpretation Arising From Off-Label Drug Promotion.
Schwartz LM; Woloshin S; Lu Z; Ross KM; Tessema FA; Peter D; Kesselheim AS
Circ Cardiovasc Qual Outcomes; 2019 Nov; 12(11):e006073. PubMed ID: 31707825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
